Zeo ScientifiX, Inc. has announced the termination of Dr. John D. Kisiday, Ph.D., as its Chief Science Officer, effective March 23, 2026. This decision was disclosed in a Form 8-K filed with the Securities and Exchange Commission (SEC) on March 27, 2026. The filing indicates that the company is making changes to its leadership team, which may impact its operational execution and strategic direction. The termination of a key executive, particularly in a scientific role, raises concerns about the company's ongoing projects and research initiatives. Investors may view this leadership change as a negative signal regarding the company's stability and future prospects. The company has not provided further details regarding the reasons for Dr. Kisiday's termination or how it plans to fill the vacancy. This development could lead to uncertainty among stakeholders and may affect the company's stock performance in the near term.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.